Identiv, Inc. announced the company joined the DoseID Consortium to strengthen its fo-cus on radio frequency identification (RFID) applications in healthcare and participate in the development of industry standards for RFID use.

DoseID connects industry participants from across the healthcare continuum to ensure RFID quality, performance, and interoperability for drug products and medical equip-ment.

Identiv RFID devices can be used in a wide range of healthcare applications, representing a significant growth opportunity for the company. Identiv offers several healthcare-focused RFID-based solutions providing secure authentication, anti-counterfeiting, trans-fer of patient information, temperature sensing, and monitoring and patient compliance.

These solutions are currently available in the market. Identiv’s additional pipeline of healthcare applications in progress utilizes its proprietary IP, including sensor-enabled RFID devices, its patented “device on metal” solution, and a range of sustainable, eco-friendly devices.

“Identiv’s new healthcare solutions are truly innovative,” said Identiv COO Dr. Manfred Mueller, Ph.D., chemistry. “For example, the recently launched uTrust Sense Syrin-geCheck is a near field communication (NFC)-enabled smart injectable dose monitoring solution ensuring patients take their medication properly. This enforces close compliance with required dosage protocols, and clinical studies can achieve compliance and trustwor-thy trial results.”

“Identiv’s membership in the DoseID Consortium reflects our vision of better patient safe-ty and our commitment to optimizing the healthcare industry’s delivery of care with RFID,” Dr. Mueller added.